ISRG · News · 20261021N
Pricing and Access Expansion
INTUITIVE SURGICAL INC · 2026-10-21 · Importance 57 · Surprise 50 · No source text
Intuitive finalized pricing actions for a subset of high-volume benign procedures where cost may limit access to da Vinci surgery. The planned actions, together with mandated reductions in China, are expected to reduce da Vinci instruments and accessories revenue per procedure by approximately 3%-5% on a constant-mix basis once fully implemented. China’s reductions begin in November 2026, while broader implementation is expected throughout 2027; planned measures include extending instrument useful lives and introducing volume-based pricing.
Key facts
- China's instrument pricing reductions begin in November 2026, with broader implementation progressing throughout 2027. source
- Intuitive said planned pricing actions and mandated reductions in China will lower da Vinci instruments and accessories (I&A) revenue per procedure by approximately 3% to 5% on a constant-mix basis once fully implemented. source
- Intuitive finalized a set of pricing actions in Q3 for a subset of high-volume benign procedures intended to expand its addressable opportunity. source
Impact estimates
| metric | direction | stage | expected | basis |
|---|---|---|---|---|
| revenue | negative | probable | -1.3% | Intuitive said planned pricing actions and mandated reductions in China will lower da Vinci instruments and accessories (I&A) revenue per… |
| revenue | negative | probable | — | China's instrument pricing reductions begin in November 2026, with broader implementation progressing throughout 2027. |